NR-50435_单克隆抗痘苗病毒(WR)B5R蛋白,残基20至275(胞外域),(类似于VMC-25),(体外生产)(单克隆抗体)
产品图片
货号/SKU
NR-50435
货号/规格
EA
库存与交货期
3-8周
人民币价格
14000
试剂海关审批
A/B级风险物质只能直接使用人购买并持有实验室有效资质,其它询客服确认
国外采购
支持/部分限制一年内购买数量
厂牌
BEI Resources(ATCC)
产品基础信息
生物安全等级建议分类:美国、1
产品描述信息
NR-50435?? Monoclonal Anti-Vaccinia Virus (WR) B5R Protein, Residues 20 to 275 (Ectodomain), (similar to VMC-25), (produced in vitro) (Monoclonal Antibodies)|Vaccinia virus|Monoclonal Anti-Vaccinia Virus (WR) B5R Protein, Residues 20 to 275 (Ectodomain), (similar to VMC-25), (produced in vitro) |-20°C or colder|GH Cohen, RJ EisenbergAcknowledgment for publications should read “The following reagent was obtained through BEI Resources, NIAID, NIH: Monoclonal Anti-Vaccinia Virus (WR) B5R Protein, Residues 20 to 275 (Ectodomain), (similar to VMC-25), (produced in vitro), NR-50435.”|Quantity limit per order for this item is 1. This item can be ordered twice a year. Orders over this limit will be sent to NIAID for approval before shipment.
Antibody Class: IgG1κ
Mouse monoclonal antibody to a recombinant form of the B5R envelope glycoprotein [B5R(275t); residues 20 to 275 comprising the ectodomain, N-terminal histidine-tagged] of the Western Reserve (WR) strain of vaccinia virus was purified from hybridoma supernatant by protein G affinity chromatography. The B cell hybridoma was generated by the fusion of SP2/0 myeloma cells with immunized BALB/c splenocytes.
Each vial contains approximately 100 ?L of purified monoclonal antibody in PBS.
NR-50435 was purified from the same hybridoma as VMC-25. The specificity of VMC-25 was determined by reactivity to B5R(275t) by ELISA and confirmed by Western blot analysis under reducing and non-reducing conditions. VMC-25 neutralizes the infectivity of the extracellular enveloped virus (EEV) form of vaccinia virus in BSC-1 cells using an EEV plaque reduction assay. VMC-25 inhibits the comet tail formation of the EEV form of vaccinia virus in BSC-1 cells using a comet tail inhibition assay.
Antibody Class: IgG1κ
Mouse monoclonal antibody to a recombinant form of the B5R envelope glycoprotein [B5R(275t); residues 20 to 275 comprising the ectodomain, N-terminal histidine-tagged] of the Western Reserve (WR) strain of vaccinia virus was purified from hybridoma supernatant by protein G affinity chromatography. The B cell hybridoma was generated by the fusion of SP2/0 myeloma cells with immunized BALB/c splenocytes.
Each vial contains approximately 100 ?L of purified monoclonal antibody in PBS.
NR-50435 was purified from the same hybridoma as VMC-25. The specificity of VMC-25 was determined by reactivity to B5R(275t) by ELISA and confirmed by Western blot analysis under reducing and non-reducing conditions. VMC-25 neutralizes the infectivity of the extracellular enveloped virus (EEV) form of vaccinia virus in BSC-1 cells using an EEV plaque reduction assay. VMC-25 inhibits the comet tail formation of the EEV form of vaccinia virus in BSC-1 cells using a comet tail inhibition assay.
主要内容
此项目的每个订单数量限制为1.此商品每年可订购两次.通过此限制的订单将在发货前发送到NIAID进行批准. 抗体类:Egg1κ小鼠单克隆抗体的B5R封套糖蛋白的重组形式[B5R(275T);通过蛋白G亲和色谱法从杂交瘤上清液中纯化西方储备(WR)痘苗病毒菌株的突氏菌,N-末端组氨酸标记物的残基20至275. B细胞杂交瘤由具有免疫BALB / C脾细胞的SP2 / 0骨髓瘤细胞的融合产生. 每个小瓶在PBS中含有大约100μl纯化的单克隆抗体.  NR-50435. VMC-25的特异性通过ELISA的反应性决定通过ELISA对B5R(275t)确定,并通过在还原和非还原条件下通过蛋白质印迹分析证实. VMC-25使用EEV斑块还原测定中和BSC-1细胞中痘苗病毒的细胞外包膜病毒(EEV)形式的感染性. VMC-25使用彗星尾抑制测定抑制BSC-1细胞中痘苗病毒的彗星尾部形成. 
厂牌介绍
BEI Resources 由美国国家过敏和传染病研究所 ( NIAID )成立,旨在为研究 A、B 和 C 类优先病原体、新兴传染病病原体、非病原微生物和其他相关微生物材料提供试剂、工具和信息到研究界。BEI Resources 获取、验证和生产科学家进行基础研究和开发改进的诊断测试、疫苗和疗法所需的试剂。通过将这些功能集中在 BEI Resources 中,可以监控科学界对这些材料的访问和使用,并确保试剂的质量控制。
除了为传染病界提供材料外,BEI Resources 还鼓励和支持研究人员和机构的材料存放。使用 BEI Resources存放材料对研究人员和研究社区有许多优势,包括安全存储、社区访问和分发;同时保护存款人的知识产权。只要有需要,BEI 资源库将作为研究人员的资源进行维护。您在 BEI Resources 的存款是一项有助于未来研究的长期投资。
BEI Resources 自 2003 年起由美国典型培养物保藏中心 (ATCC) 根据合同管理。2016 年 5 月, ATCC获得了一份为期七年的继续管理 BEI Resources的合同。合同范围已扩大到更全面的研究目录材料,包括由其他政府支持的研究项目存放的材料,将提供给生物防御和新兴传染病科学界。真菌、寄生虫、载体和其他相关材料已添加到现有的细菌、病毒和毒素试剂中,涵盖 NIAID A、B 和 C 类优先病原体和 NIAID 指定的新发传染病病原体和生物。
品牌标识
可能感兴趣的内容
2024-08-29
2022-01-10
2021-10-31
2022-04-01
2022-04-01
2021-12-13
2024-05-19
2022-03-31
2020-08-04
2021-12-21
2020-08-04
2024-01-21
2022-04-01
2022-04-01
2022-12-13
2022-04-01